Heron Therapeutics (HRTX) Revenue & Revenue Breakdown
Heron Therapeutics Revenue Highlights
Latest Revenue (Y)
$127.04M
Latest Revenue (Q)
$46.54M
Main Segment (Y)
C I N V A N T I
Heron Therapeutics Revenue by Period
Heron Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $127.04M | 17.99% |
| 2022-12-31 | $107.67M | 24.70% |
| 2021-12-31 | $86.35M | -2.59% |
| 2020-12-31 | $88.64M | -39.28% |
| 2019-12-31 | $145.97M | 88.41% |
| 2018-12-31 | $77.47M | 151.81% |
| 2017-12-31 | $30.77M | 2305.55% |
| 2016-12-31 | $1.28M | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | -100.00% |
| 2011-12-31 | $646.00K | -50.35% |
| 2010-12-31 | $1.30M | 3.17% |
| 2009-12-31 | $1.26M | 241.73% |
| 2008-12-31 | $369.00K | -10.44% |
| 2007-12-31 | $412.00K | 100.00% |
| 2006-12-31 | - | -100.00% |
| 2005-12-31 | $5.39M | -0.24% |
| 2004-12-31 | $5.40M | 11.47% |
| 2003-12-31 | $4.85M | -16.63% |
| 2002-12-31 | $5.82M | 32.54% |
| 2001-12-31 | $4.39M | 30.35% |
| 2000-12-31 | $3.37M | -83.50% |
| 1999-12-31 | $20.40M | 2.00% |
| 1998-12-31 | $20.00M | 9.29% |
| 1997-12-31 | $18.30M | -2.14% |
| 1996-12-31 | $18.70M | 16.15% |
| 1995-12-31 | $16.10M | 1.26% |
| 1994-12-31 | $15.90M | -20.10% |
| 1993-12-31 | $19.90M | - |
Heron Therapeutics generated $127.04M in revenue during NA 2023, up 17.99% compared to the previous quarter, and up 163.98% compared to the same period a year ago.
Heron Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $46.54M | 34.24% |
| 2024-03-31 | $34.67M | 1.28% |
| 2023-12-31 | $34.23M | 8.90% |
| 2023-09-30 | $31.43M | -1.03% |
| 2023-06-30 | $31.76M | 7.25% |
| 2023-03-31 | $29.61M | -1.38% |
| 2022-12-31 | $30.03M | 13.07% |
| 2022-09-30 | $26.56M | -3.88% |
| 2022-06-30 | $27.63M | 17.79% |
| 2022-03-31 | $23.46M | 13.57% |
| 2021-12-31 | $20.66M | -11.08% |
| 2021-09-30 | $23.23M | 3.51% |
| 2021-06-30 | $22.44M | 12.11% |
| 2021-03-31 | $20.02M | -2.85% |
| 2020-12-31 | $20.61M | 3.21% |
| 2020-09-30 | $19.96M | -11.92% |
| 2020-06-30 | $22.67M | -10.76% |
| 2020-03-31 | $25.40M | -27.60% |
| 2019-12-31 | $35.08M | -17.69% |
| 2019-09-30 | $42.62M | 16.27% |
| 2019-06-30 | $36.66M | 16.00% |
| 2019-03-31 | $31.60M | 9.56% |
| 2018-12-31 | $28.84M | 45.78% |
| 2018-09-30 | $19.79M | 14.52% |
| 2018-06-30 | $17.28M | 49.36% |
| 2018-03-31 | $11.57M | 15.06% |
| 2017-12-31 | $10.05M | 17.28% |
| 2017-09-30 | $8.57M | 0.73% |
| 2017-06-30 | $8.51M | 134.31% |
| 2017-03-31 | $3.63M | 183.97% |
| 2016-12-31 | $1.28M | 93.49% |
| 2016-09-30 | $661.00K | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | -100.00% |
| 2011-06-30 | $251.00K | -36.46% |
| 2011-03-31 | $395.00K | 120.67% |
| 2010-12-31 | $179.00K | -49.00% |
| 2010-09-30 | $351.00K | -33.77% |
| 2010-06-30 | $530.00K | 119.92% |
| 2010-03-31 | $241.00K | 97.54% |
| 2009-12-31 | $122.00K | -89.08% |
| 2009-09-30 | $1.12M | 7878.57% |
| 2009-06-30 | $14.00K | 75.00% |
| 2009-03-31 | $8.00K | -61.90% |
| 2008-12-31 | $21.00K | -67.19% |
| 2008-09-30 | $64.00K | -57.89% |
| 2008-06-30 | $152.00K | 14.29% |
| 2008-03-31 | $133.00K | 0.76% |
| 2007-12-31 | $132.00K | - |
Heron Therapeutics generated $46.54M in revenue during Q2 2024, up 34.24% compared to the previous quarter, and up 157.16% compared to the same period a year ago.
Heron Therapeutics Revenue Breakdown
Heron Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Z Y N R E L E F | $17.73M | $10.20M | $2.92M | - | - |
| S U S T O L | $13.06M | $10.23M | $9.91M | $800.00K | $13.80M |
| C I N V A N T I | $94.87M | $87.25M | $73.51M | $87.80M | $132.20M |
Heron Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: C I N V A N T I (75.50%), Z Y N R E L E F (14.11%), and S U S T O L (10.39%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Z Y N R E L E F | $5.01M | $10.07M | $4.13M | $3.53M | $3.90M | $2.72M | $2.52M | $1.10M | $824.00K | $2.10M | - | - | - | - | - | - | - | - |
| C I N V A N T I | $25.62M | $47.54M | $24.47M | $22.86M | $23.07M | $21.17M | $22.66M | $20.30M | $17.31M | $18.00M | $19.70M | $18.50M | $20.20M | $19.80M | $22.60M | $25.20M | $34.60M | $36.40M |
| S U S T O L | $3.62M | $7.24M | $2.84M | $2.98M | $3.05M | $2.67M | $2.45M | $2.10M | $2.52M | $3.10M | $2.70M | $1.50M | $400.00K | $200.00K | $100.00K | $200.00K | $500.00K | $6.20M |
Heron Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: C I N V A N T I (74.81%), Z Y N R E L E F (14.64%), and S U S T O L (10.56%).
Heron Therapeutics Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Z Y N R E L E F | $3.53M | $3.90M | $2.72M | $2.52M | $1.10M | $824.00K | $2.10M | - | - | - | - | - | - | - | - |
| C I N V A N T I | $22.86M | $23.07M | $21.17M | $22.66M | $20.30M | $17.31M | $18.00M | $19.70M | $18.50M | $20.20M | $19.80M | $22.60M | $25.20M | $34.60M | $36.40M |
| S U S T O L | $2.98M | $3.05M | $2.67M | $2.45M | $2.10M | $2.52M | $3.10M | $2.70M | $1.50M | $400.00K | $200.00K | $100.00K | $200.00K | $500.00K | $6.20M |
Heron Therapeutics's latest quarterly revenue breakdown by geography, as of Mar 23: C I N V A N T I (77.81%), Z Y N R E L E F (12.03%), and S U S T O L (10.16%).
Heron Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HRTX | Heron Therapeutics | $127.04M | $46.54M |
| HOOK | HOOKIPA Pharma | $20.13M | - |
| MREO | Mereo BioPharma Group | $10.00M | - |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| PDSB | PDS Bio | - | - |
| DAWN | Day One Biopharmaceuticals | - | $8.19M |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| ELDN | Eledon Pharmaceuticals | - | - |
HRTX Revenue FAQ
What is Heron Therapeutics’s yearly revenue?
Heron Therapeutics's yearly revenue for 2023 was $127.04M, representing an increase of 17.99% compared to 2022. The company's yearly revenue for 2022 was $107.67M, representing an increase of 24.70% compared to 2021. HRTX's yearly revenue for 2021 was $86.35M, representing a decrease of -2.59% compared to 2020.
What is Heron Therapeutics’s quarterly revenue?
Heron Therapeutics's quarterly revenue for Q2 2024 was $46.54M, a 34.24% increase from the previous quarter (Q1 2024), and a 46.53% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $34.67M, a 1.28% increase from the previous quarter (Q4 2023), and a 17.07% increase year-over-year (Q1 2023). HRTX's quarterly revenue for Q4 2023 was $34.23M, a 8.90% increase from the previous quarter (Q3 2023), and a 14.00% increase year-over-year (Q4 2022).
What is Heron Therapeutics’s revenue growth rate?
Heron Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 47.13%, and for the last 5 years (2019-2023) was -12.96%.
What are Heron Therapeutics’s revenue streams?
Heron Therapeutics's revenue streams in c 23 are Z Y N R E L E F, S U S T O L, and C I N V A N T I. Z Y N R E L E F generated $17.73M in revenue, accounting 14.11% of the company's total revenue, up 73.86% year-over-year. S U S T O L generated $13.06M in revenue, accounting 10.39% of the company's total revenue, up 27.62% year-over-year. C I N V A N T I generated $94.87M in revenue, accounting 75.50% of the company's total revenue, up 8.74% year-over-year.
What is Heron Therapeutics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Heron Therapeutics was C I N V A N T I. This segment made a revenue of $94.87M, representing 75.50% of the company's total revenue.